CXCL12 Modulates Prostate Cancer Cell Adhesion by Altering the Levels or Activities of β1-Containing Integrins

The mechanisms by which prostate cancer (PCa) cell adhesion and migration are controlled during metastasis are not well understood. Here, we studied the effect of CXCL12 in PCa cell adhesion and spreading in DU145 and PC3 cell lines using as substrates collagen I, fibronectin (FN), and their recombi...

Full description

Saved in:
Bibliographic Details
Main Authors: Mehdi Dehghani, Sedigheh Kianpour, Ana Zangeneh, Zohreh Mostafavi-Pour
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:International Journal of Cell Biology
Online Access:http://dx.doi.org/10.1155/2014/981750
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850177275764408320
author Mehdi Dehghani
Sedigheh Kianpour
Ana Zangeneh
Zohreh Mostafavi-Pour
author_facet Mehdi Dehghani
Sedigheh Kianpour
Ana Zangeneh
Zohreh Mostafavi-Pour
author_sort Mehdi Dehghani
collection DOAJ
description The mechanisms by which prostate cancer (PCa) cell adhesion and migration are controlled during metastasis are not well understood. Here, we studied the effect of CXCL12 in PCa cell adhesion and spreading in DU145 and PC3 cell lines using as substrates collagen I, fibronectin (FN), and their recombinant fragments. CXCL12 treatment increased β1 integrin-dependent PC3 cell adhesion on FN which correlated with increased focal adhesion kinase activation. However neither α5β1 nor α4β1 subunits were involved in this adhesion. By contrast, CXCL12 decreased DU145 adhesion and spreading on FN by downregulating α5 and β1 integrin expression. To demonstrate the clinical relevance of CXCL12 in PCa, we measured CXCL12 levels in plasma by using ELISA and found that the chemokine is elevated in PCa patients when compared to controls. The high concentration of CXCL12 in patients suffering from PCa in comparison to those with benign disease or healthy individuals implicates CXCL12 as a potential biomarker for PCa. In addition these data show that CXCL12 may be crucial in controlling PCa cell adhesion on fibronectin and collagen I, possibly via crosstalk with integrin receptors and/or altering the expression levels of integrin subunits.
format Article
id doaj-art-c3129da92eb34d309a5bdfa0040a54b1
institution OA Journals
issn 1687-8876
1687-8884
language English
publishDate 2014-01-01
publisher Wiley
record_format Article
series International Journal of Cell Biology
spelling doaj-art-c3129da92eb34d309a5bdfa0040a54b12025-08-20T02:19:01ZengWileyInternational Journal of Cell Biology1687-88761687-88842014-01-01201410.1155/2014/981750981750CXCL12 Modulates Prostate Cancer Cell Adhesion by Altering the Levels or Activities of β1-Containing IntegrinsMehdi Dehghani0Sedigheh Kianpour1Ana Zangeneh2Zohreh Mostafavi-Pour3Department of Biochemistry, Shiraz University of Medical Sciences, Shiraz 71348-14336, IranDepartment of Biochemistry, Shiraz University of Medical Sciences, Shiraz 71348-14336, IranSchool of Public Health, University of Texas Health Science Center, Houston, TX 77030, USADepartment of Biochemistry, Shiraz University of Medical Sciences, Shiraz 71348-14336, IranThe mechanisms by which prostate cancer (PCa) cell adhesion and migration are controlled during metastasis are not well understood. Here, we studied the effect of CXCL12 in PCa cell adhesion and spreading in DU145 and PC3 cell lines using as substrates collagen I, fibronectin (FN), and their recombinant fragments. CXCL12 treatment increased β1 integrin-dependent PC3 cell adhesion on FN which correlated with increased focal adhesion kinase activation. However neither α5β1 nor α4β1 subunits were involved in this adhesion. By contrast, CXCL12 decreased DU145 adhesion and spreading on FN by downregulating α5 and β1 integrin expression. To demonstrate the clinical relevance of CXCL12 in PCa, we measured CXCL12 levels in plasma by using ELISA and found that the chemokine is elevated in PCa patients when compared to controls. The high concentration of CXCL12 in patients suffering from PCa in comparison to those with benign disease or healthy individuals implicates CXCL12 as a potential biomarker for PCa. In addition these data show that CXCL12 may be crucial in controlling PCa cell adhesion on fibronectin and collagen I, possibly via crosstalk with integrin receptors and/or altering the expression levels of integrin subunits.http://dx.doi.org/10.1155/2014/981750
spellingShingle Mehdi Dehghani
Sedigheh Kianpour
Ana Zangeneh
Zohreh Mostafavi-Pour
CXCL12 Modulates Prostate Cancer Cell Adhesion by Altering the Levels or Activities of β1-Containing Integrins
International Journal of Cell Biology
title CXCL12 Modulates Prostate Cancer Cell Adhesion by Altering the Levels or Activities of β1-Containing Integrins
title_full CXCL12 Modulates Prostate Cancer Cell Adhesion by Altering the Levels or Activities of β1-Containing Integrins
title_fullStr CXCL12 Modulates Prostate Cancer Cell Adhesion by Altering the Levels or Activities of β1-Containing Integrins
title_full_unstemmed CXCL12 Modulates Prostate Cancer Cell Adhesion by Altering the Levels or Activities of β1-Containing Integrins
title_short CXCL12 Modulates Prostate Cancer Cell Adhesion by Altering the Levels or Activities of β1-Containing Integrins
title_sort cxcl12 modulates prostate cancer cell adhesion by altering the levels or activities of β1 containing integrins
url http://dx.doi.org/10.1155/2014/981750
work_keys_str_mv AT mehdidehghani cxcl12modulatesprostatecancercelladhesionbyalteringthelevelsoractivitiesofb1containingintegrins
AT sedighehkianpour cxcl12modulatesprostatecancercelladhesionbyalteringthelevelsoractivitiesofb1containingintegrins
AT anazangeneh cxcl12modulatesprostatecancercelladhesionbyalteringthelevelsoractivitiesofb1containingintegrins
AT zohrehmostafavipour cxcl12modulatesprostatecancercelladhesionbyalteringthelevelsoractivitiesofb1containingintegrins